Hemp-based CT contrast | Increasing LDCT rates | California amends law on ICM administration | Masked lung cancer on CT

It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness. 

Experts are working to develop agents they say can enhance imaging studies without the risks associated with traditional contrast media. 

The update eliminates the requirement for a physician to be on-site and now allows techs to perform venipuncture and conduct contrast administration under remote supervision.

Experts recently developed a new set of recommendations to help providers better navigate decisions related to contrast administration, sharing their guidance in Insights into Imaging. 

The college is urging the federal payment program to modify its policies to reflect expanded coverage for CT-based colorectal cancer screening. 

Experts are hopeful that routine CT scans could serve the dual purpose of screening patients for both osteoporosis and heart disease. 

The device is intended for use in orthopedics, where weight-bearing imaging can make a significant difference in diagnosis and treatment.

At the start of 2025, CMS issued a national coverage determination on CTC that led to widespread insurance coverage of the exam. 

Such baseline neuroimaging markers could provide clues into how patients will respond to treatment, and thrombolysis in particular.

For many patients with interstitial lung disease, cancer could go undetected for years, putting them at risk of disease progression that would require more extensive treatment.

AI is only as effective as the data it was trained on, and many datasets lack diversity in terms of patient body mass index.